-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Alpha Teknova, Inc. (NASDAQ:TKNO) CEO Stephen Gunstream Acquires 18,000 Shares of Stock
Alpha Teknova, Inc. (NASDAQ:TKNO) CEO Stephen Gunstream Acquires 18,000 Shares of Stock
Alpha Teknova, Inc. (NASDAQ:TKNO – Get Rating) CEO Stephen Gunstream acquired 18,000 shares of the firm's stock in a transaction on Monday, August 15th. The stock was purchased at an average cost of $5.13 per share, with a total value of $92,340.00. Following the completion of the transaction, the chief executive officer now owns 18,000 shares in the company, valued at $92,340. The acquisition was disclosed in a filing with the SEC, which is available at the SEC website.
Alpha Teknova Stock Performance
Shares of TKNO stock opened at $5.18 on Tuesday. The company has a debt-to-equity ratio of 0.13, a quick ratio of 6.10 and a current ratio of 6.77. Alpha Teknova, Inc. has a one year low of $4.23 and a one year high of $28.64. The company's 50-day simple moving average is $7.42 and its 200-day simple moving average is $11.27. The stock has a market capitalization of $145.12 million, a price-to-earnings ratio of -7.72 and a beta of -1.05.
Get Alpha Teknova alerts:Alpha Teknova (NASDAQ:TKNO – Get Rating) last issued its quarterly earnings results on Wednesday, August 10th. The company reported ($0.22) EPS for the quarter, topping the consensus estimate of ($0.25) by $0.03. Alpha Teknova had a negative net margin of 43.93% and a negative return on equity of 13.25%. During the same quarter in the previous year, the business earned ($0.52) EPS. Equities analysts anticipate that Alpha Teknova, Inc. will post -0.94 earnings per share for the current fiscal year.
Wall Street Analysts Forecast Growth
Separately, Stephens decreased their price objective on shares of Alpha Teknova from $22.00 to $15.00 and set an "overweight" rating for the company in a research report on Thursday, August 11th.Hedge Funds Weigh In On Alpha Teknova
Large investors have recently modified their holdings of the stock. Alpha Paradigm Partners LLC acquired a new stake in Alpha Teknova during the fourth quarter worth about $190,000. Parian Global Management LP acquired a new stake in Alpha Teknova during the fourth quarter worth about $780,000. Ranger Investment Management L.P. raised its stake in Alpha Teknova by 18.1% during the fourth quarter. Ranger Investment Management L.P. now owns 264,446 shares of the company's stock worth $5,416,000 after acquiring an additional 40,554 shares during the period. New York State Common Retirement Fund raised its stake in Alpha Teknova by 19.3% during the fourth quarter. New York State Common Retirement Fund now owns 35,019 shares of the company's stock worth $717,000 after acquiring an additional 5,657 shares during the period. Finally, State Board of Administration of Florida Retirement System acquired a new stake in Alpha Teknova during the second quarter worth about $129,000. Institutional investors own 25.51% of the company's stock.
Alpha Teknova Company Profile
(Get Rating)
Alpha Teknova, Inc provides critical reagents for life sciences market in the United States and internationally. Its reagents enable the discovery, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.
Further Reading
- Get a free copy of the StockNews.com research report on Alpha Teknova (TKNO)
- 3 Blowout Earnings Reports That Could Mark Turning Points
- Skyworks Solutions Is Worth A Look At These Prices
- Will CrowdStrike Extend Its Streak Of Topping Earnings Views?
- 3 Stocks Set to Lead the Nasdaq Bull Market
- MarketBeat Podcast: ESG – Profitably Invest Your Values
Receive News & Ratings for Alpha Teknova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Teknova and related companies with MarketBeat.com's FREE daily email newsletter.
Alpha Teknova, Inc. (NASDAQ:TKNO – Get Rating) CEO Stephen Gunstream acquired 18,000 shares of the firm's stock in a transaction on Monday, August 15th. The stock was purchased at an average cost of $5.13 per share, with a total value of $92,340.00. Following the completion of the transaction, the chief executive officer now owns 18,000 shares in the company, valued at $92,340. The acquisition was disclosed in a filing with the SEC, which is available at the SEC website.
阿尔法·特克诺瓦公司(纳斯达克代码:TKNO-GET Rating)首席执行官斯蒂芬·冈斯特雷姆在8月15日(星期一)的一次交易中收购了18,000股该公司股票。这只股票是以每股5.13美元的平均价格购买的,总价值为92,340.00美元。交易完成后,首席执行官现在拥有该公司18,000股股份,价值92,340美元。这笔收购是在提交给美国证券交易委员会的一份文件中披露的,该文件可以在美国证券交易委员会的网站上看到。
Alpha Teknova Stock Performance
阿尔法·特克诺瓦股票表现
Shares of TKNO stock opened at $5.18 on Tuesday. The company has a debt-to-equity ratio of 0.13, a quick ratio of 6.10 and a current ratio of 6.77. Alpha Teknova, Inc. has a one year low of $4.23 and a one year high of $28.64. The company's 50-day simple moving average is $7.42 and its 200-day simple moving average is $11.27. The stock has a market capitalization of $145.12 million, a price-to-earnings ratio of -7.72 and a beta of -1.05.
周二,TKNO的股票开盘报5.18美元。该公司的负债权益比率为0.13,速动比率为6.10,流动比率为6.77。Alpha Tenowva,Inc.的一年低点为4.23美元,一年高位为28.64美元。该公司的50日简单移动均线切入位在7.42美元,200日简单移动均线切入位在11.27美元。该股市值为1.4512亿美元,市盈率为-7.72,贝塔系数为-1.05。
Alpha Teknova (NASDAQ:TKNO – Get Rating) last issued its quarterly earnings results on Wednesday, August 10th. The company reported ($0.22) EPS for the quarter, topping the consensus estimate of ($0.25) by $0.03. Alpha Teknova had a negative net margin of 43.93% and a negative return on equity of 13.25%. During the same quarter in the previous year, the business earned ($0.52) EPS. Equities analysts anticipate that Alpha Teknova, Inc. will post -0.94 earnings per share for the current fiscal year.
阿尔法·泰克诺瓦(纳斯达克代码:TKNO-GET Rating)上一次发布季度收益报告是在8月10日星期三。该公司公布本季度每股收益(0.22美元),比普遍预期的(0.25美元)高出0.03美元。阿尔法·特克诺瓦的净利润率为负43.93%,股本回报率为负13.25%。在去年同一季度,该业务实现每股收益(0.52美元)。股票分析师预计,阿尔法·特克诺瓦公司本财年的每股收益将达到0.94美元。
Wall Street Analysts Forecast Growth
华尔街分析师预测经济增长
Hedge Funds Weigh In On Alpha Teknova
对冲基金对阿尔法·特克诺瓦的看法
Large investors have recently modified their holdings of the stock. Alpha Paradigm Partners LLC acquired a new stake in Alpha Teknova during the fourth quarter worth about $190,000. Parian Global Management LP acquired a new stake in Alpha Teknova during the fourth quarter worth about $780,000. Ranger Investment Management L.P. raised its stake in Alpha Teknova by 18.1% during the fourth quarter. Ranger Investment Management L.P. now owns 264,446 shares of the company's stock worth $5,416,000 after acquiring an additional 40,554 shares during the period. New York State Common Retirement Fund raised its stake in Alpha Teknova by 19.3% during the fourth quarter. New York State Common Retirement Fund now owns 35,019 shares of the company's stock worth $717,000 after acquiring an additional 5,657 shares during the period. Finally, State Board of Administration of Florida Retirement System acquired a new stake in Alpha Teknova during the second quarter worth about $129,000. Institutional investors own 25.51% of the company's stock.
大型投资者最近调整了对该股的持有量。Alpha Paradigm Partners LLC在第四季度收购了Alpha Tenowva的新股份,价值约19万美元。帕里安全球管理有限公司在第四季度收购了阿尔法·特克诺瓦的新股份,价值约78万美元。Ranger Investment Management L.P.在第四季度将其在Alpha Tenowva的持股增加了18.1%。Ranger Investment Management L.P.在此期间增持了40,554股,现在拥有264,446股该公司股票,价值5,416,000美元。纽约州共同退休基金在第四季度将其在Alpha Tenowva的持股增加了19.3%。纽约州共同退休基金现在拥有35,019股该公司的股票,价值717,000美元,在此期间又购买了5,657股。最后,佛罗里达州退休系统管理委员会在第二季度收购了阿尔法·特克诺瓦的新股份,价值约12.9万美元。机构投资者持有该公司25.51%的股票。
Alpha Teknova Company Profile
阿尔法·特克诺瓦公司简介
(Get Rating)
(获取评级)
Alpha Teknova, Inc provides critical reagents for life sciences market in the United States and internationally. Its reagents enable the discovery, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.
阿尔法·特诺瓦公司为美国和国际生命科学市场提供关键试剂。它的试剂使生物制药产品的发现、开发和生产成为可能,如药物疗法、新型疫苗和分子诊断。该公司提供用于细胞生长和克隆的预先浇注的培养基板;用于细胞扩增的液体细胞培养液和补充剂;以及用于样品处理、再悬浮和纯化的分子生物试剂。
Further Reading
进一步阅读
- Get a free copy of the StockNews.com research report on Alpha Teknova (TKNO)
- 3 Blowout Earnings Reports That Could Mark Turning Points
- Skyworks Solutions Is Worth A Look At These Prices
- Will CrowdStrike Extend Its Streak Of Topping Earnings Views?
- 3 Stocks Set to Lead the Nasdaq Bull Market
- MarketBeat Podcast: ESG – Profitably Invest Your Values
- 免费获取StockNews.com关于阿尔法·特克诺瓦的研究报告(TKNO)
- 3份井喷式收益报告可能标志着转折点
- Skyworks Solutions值得看看这些价格
- CrowdStrike是否会延续其盈利排行榜榜首的势头?
- 3只股票将引领纳斯达克牛市
- MarketBeat播客:ESG--有利可图地投资你的价值
Receive News & Ratings for Alpha Teknova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Teknova and related companies with MarketBeat.com's FREE daily email newsletter.
接收阿尔法·特克诺瓦日报的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Alpha Tenowva和相关公司的最新新闻和分析师评级的每日简要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧